We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
36 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
650% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 2
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
184% more capital invested
Capital invested by funds: $16.2M → $45.8M (+$29.7M)
38% more funds holding
Funds holding: 26 → 36 (+10)
64% less call options, than puts
Call options by funds: $101K | Put options by funds: $277K
Holders
36
Holders Change
+10
Holders Change %
+38.46%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
15
Reduced
2
Closed
2
Calls
$101K
Puts
$277K
Net Calls
-$176K
Net Calls Change
-$245K
Top Buyers
| 1 |
BM
Bridger Management
New York
|
+$4.19M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.85M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.52M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$1.92M |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
+$1.33M |
